Tesamorelin is FDA-approved for reducing visceral fat in HIV patients and is a highly stable GHRH analog similar to CJC-1295.
FDA data shows its primary benefit is fat reduction rather than direct muscle building. While it does stimulate GH release, CJC-1295 is more commonly used in muscle-building protocols due to its established track record.